MEDICAL ADVOCATES
 Prisoners
  Hepatitis C
General Reports          
Epidemiology/Incidence Studies
 Clinical Management
 Drugs




Also refer to HCV data in US State Studies and Reports







 
Prison Health Disease Index Main New and Noteworthy Home Page
Last Update:  May 15, 2012
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
 

                   Journal Papers, Abstracts, and Commentaries

 
FULL-TEXT ARTICLE
 Prison puzzle: Treating hepatitis C.
 Webster PC.
CMAJ. 2012 May 7.
 Paper

FULL-TEXT LETTER
 Tuberculosis Screening before Anti-Hepatitis C Virus Therapy in Prisons.
 Babudieri S, Soddu A, Murino M, et al
Emerg Infect Dis. 2012 Apr;18(4):689-91
 Commentary

Hepatitis C education and support in Australian prisons: preliminary findings of a nationwide survey.
Tyler J, Tolliday L.
Health Promot J Austr. 2009 Apr;20(1):37-41
 Abstract

Clinical Outcomes of Hepatitis C Treatment in a Prison Setting: Feasibility and
Effectiveness for Challenging Treatment Populations.
Maru DS, Bruce RD, Basu S, Altice FL, et al 
Clin Infect Dis. 2008 Aug 20.
Abstract

Treating hepatitis C in the prison population is cost-saving.
Tan JA, Joseph TA, Saab S.
Hepatology. 2008 Jul 16.
 Abstract
 
A WEEK IN REVIW FEATURED REPORT
A golden opportunity: the treatment of hepatitis C in HIV-infected inmates.
McGovern B .
J Addict Dis. 2008;27(2):69-73.
 Abstract
 
Increasing the uptake of hepatitis C virus testing among injecting drug users in
specialist drug treatment and prison settings by using dried blood spots for
diagnostic testing: a cluster randomized controlled trial.
Hickman M, McDonald T, Judd A, et al 
 J Viral Hepat. 2007 Dec 11
Abstract
 
FULL TEXT ARTICLE
Deadly disregard: government refusal to implement evidence-based measures to
prevent HIV and hepatitis C virus infections in prisons
Elliott R   
CMAJ 2007 177: 262-264.
 Paper
 
FULL TEXT ARTICLE
Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities
Calzavara L, Ramuscak N, Burchell AN, et al 
CMAJ 2007 177: 257-261
 Paper
 
FULL TEXT ARTICLE
 Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons
Poulin C, Alary M, Lambert G, et al 
CMAJ 2007 177: 252-256
 Paper
 
FULL TEXT PDF ARTICLE
Prisons, hepatitis C and harm minimisation.
Levy MH, Treloar C, McDonald RM, Booker N. 
Med J Aust. 2007 Jun 18;186(12):647-9.
 Paper
 
FULL TEXT PDF ARTICLE
 I just keep thinking I haven't got it because I'm not yellow: A qualitative study of the factors
that influence the uptake of Hepatitis C testing by prisoners.
Khaw FM, Stobbart L, Murtagh MJ.
BMC Public Health. 2007 Jun 7;7(1):98
 Paper
 
Hepatitis C in prison settings: screening and therapy are improving.
 Remy Et Les Ucsa De France AJ.  
Presse Med. 2006 Sep;35(9 Pt 1):1249-54.
Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL TEXT PDF ARTICLE
 The Case of Scott Ortiz: A clash between criminal justice and public health.
Venters HD, Razvi AM, Tobia MS, Drucker E.
Harm Reduct J. 2006 Jul 24;3(1):21
PDF Paper
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL TEXT ARTICLE
[US]  Legal Environment and Hepatitis C Treatment
Positive Populations  Vol 8, No 1
 Paper
 
FULL-TEXT PDF ARTICLE
 Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on
reception into prison.
Sutton AJ, Edmunds WJ, Gill ON.
BMC Public Health. 2006 Jun 27;6(1):170
 Paper
 
A Missed Opportunity: Hepatitis C Screening of Prisoners
Macalino, GE  Dhawan D,  Rich JD 
Am J Public Health 2005;95 1739-1740
 Abstract

Hepatitis C and HIV in incarcerated populations: fights, bites, searches, and syringes
Zalumas JC, Rose CD.
J Assoc Nurses AIDS Care. 2003 Sep-Oct;14(5 Suppl):108S-115S.
 Abstract
Epidemiology/Incidence/Challenges Studies
 
          Journal Papers, Abstracts, and Commentaries
 
 
Estimating the variability in the risk of infection for hepatitis C in the Glasgow injecting drug user population.
 Sutton AJ, McDonald SA, Palmateer N,  et al
Epidemiol Infect. 2012 Mar 30:1-0
 Abstract

Comparison of hepatitis C virus treatment between incarcerated and community patients.
Rice JP, Burnett D, Tsotsis H, et al
 Hepatology. 2012 Apr 13.
Abstract

'Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.
 Peña-Orellana M, Hernández-Viver A,  et al
J Health Care Poor Underserved. 2011;22(3):962-82.
 Abstract

Hepatitis C and B prevalence in Spanish prisons.
Saiz de la Hoya P, Marco A, García-Guerrero J, Rivera A
Eur J Clin Microbiol Infect Dis. 2011 Jan 28.
 Abstract

A "One-Two Punch" Leading to Hepatitis C Seroconversion.
 Nagami EH, Kim AY, Birch CE, et al
Clin Infect Dis. 2010 Dec 28.
 Abstract

Frequent multiple hepatitis C virus infections among injection drug users in a prison setting.
Pham ST, Bull RA, Bennett JM,  et al
Hepatology. 2010 Nov;52(5):1564-72
 Abstract

FULL-TEXT PDF ARTICLE
Incidence of primary hepatitis C infection and risk factors for transmission in an Australian
prisoner cohort.
Teutsch S, Luciani F, Scheuer N, et al
BMC Public Health. 2010 Oct 22;10(1):633
 Paper

A WEEK-IN-REVIEW FEATURED REPORT
High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C.
Bate JP, Colman AJ, Frost PJ, Shaw DR, Harley HA.  
J Gastroenterol Hepatol. 2010 Jul;25(7):1276-1280
 Abstract

Chronic hepatitis C in the state prison system: insights into the problems and possible solutions.
Imperial JC. 
Expert Rev Gastroenterol Hepatol. 2010 Jun;4(3):355-64
 Abstract

Seropositivity of hepatitis C in prison inmates of Pakistan--a cross sectional study in prisons of Sindh.
Gorar ZA, Zulfikar I.
J Pak Med Assoc. 2010 Jun;60(6):476-9.
 Abstract

Establishment of a successful assessment and treatment service for
Australian prison inmates with chronic hepatitis C.
Boonwaat L, Haber PS, Levy MH, Lloyd AR.
 Med J Aust. 2010 May 3;192(9):496-500.
 Abstract

Incidence and risk for acute hepatitis C infection during imprisonment in Australia.
Dolan K, Teutsch S, Scheuer N, et al  
Eur J Epidemiol. 2010 Jan 19.
Abstract

Presence of hepatitis C virus in syringes confiscated in prisons in Australia.
Dolan K, Larney S, Jacka B, Rawlinson W.
  J Gastroenterol Hepatol. 2009 Oct;24(10):1655-7
 Abstract

FULL TEXT ARTICLE
Predictive markers for hepatitis C virus infection among Brazilian inmates.
Coelho HC, de Oliveira SA, Miguel JC,
Rev Soc Bras Med Trop. 2009 Jul-Aug;42(4):369-72
 Paper

HCV-related mortality among male prison inmates in Texas, 1994-2003.
Harzke AJ, Baillargeon JG, Kelley MF, et al  
Ann Epidemiol. 2009 May 12.
Abstract

Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER, Bi P, Ryan P. 
Int J Infect Dis. 2009 Mar;13(2):201-8.
Abstract
 
Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison.
Murcia J, Portilla J, Bedia M, Palazón JM, et al  
 Enferm Infecc Microbiol Clin. 2009 Feb 24
Abstract
 
Viral Hepatitis in Incarcerated Adults: A Medical and Public Health Concern.
Hunt DR, Saab S.
Am J Gastroenterol. 2009 Feb 24
 Abstract
 
Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER, Bi P, Ryan P
 Int J Infect Dis. 2008 Sep 12.
 Abstract
 
Correlates of hepatitis C virus infection among incarcerated Ghanaians: a national multicentre
study.
Adjei AA, Armah HB, Gbagbo F, et al  
 J Med Microbiol. 2007 Mar;56(Pt 3):391-7.
Abstract
 
Acute hepatitis C virus infection in incarcerated injection drug users.
McGovern BH, Wurcel A, Kim AY, et al
Clin Infect Dis. 2006 Jun 15;42(12):1663-70.
 Abstract
 
The prevalence of HCV antibody in South Australian prisoners.
Miller ER, Bi P, Ryan P. et al   
J Infect. 2005 Nov 25;
 Abstract
 
Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and
prevention.
Weinbaum CM, Sabin KM, Santibanez SS.
AIDS. 2005 Oct;19 Suppl 3:S41-6.
 Abstract
 
Community incidence of hepatitis B and C among reincarcerated women.
Macalino GE, Vlahov D, Dickinson BP, et al 
Clin Infect Dis. 2005 Oct 1;41(7):998-1002.
Abstract
 
Prevalence and Incidence of HIV, Hepatitis B Virus, and Hepatitis C Virus Infections
Among Males in Rhode Island Prisons.
Macalino GE, Vlahov D, Sanford-Colby S, et al
Am J Public Health. 2004 Jul;94(7):1218-23.
 Abstract
 
High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
Lehmann M, Meyer MF, Monazahian M,  et al
J Med Virol. 2004 Jul;73(3):387-91.
 Abstract

Hepatitis C transmission and HIV post-exposure prophylaxis after needle-and syringe-
sharing in Australian prisons.
O'Sullivan BG, Levy MH, Dolan KA, et al.
Med J Aust 2003 Jun 2;178(11):546-549
 Abstract
   
  FULL-TEXT ARTICLE
 Hepatitis B Outbreak in a State Correctional Facility, 2000.
CDC
MMWR June 29, 2001 / 50(25);529-532
Paper
Prevention
 

          Journal Papers, Abstracts, and Commentaries

  FULL-TEXT ARTICLE
Prevention and control of infections with hepatitis viruses in correctional settings. Centers
for Disease Control and Prevention.
Weinbaum C, Lyerla R, Margolis HS;
MMWR Recomm Rep. 2003 Mar 14;52(10):205-14.
Paper
Clinical  Management
Drugs

         Journal Papers, Abstracts, and Commentaries

 
High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C.
Bate JP, Colman AJ, Frost PJ, et al  
J Gastroenterol Hepatol. 2010 Jul;25(7):1276-1280
 Abstract

New opportunities for the management and therapy of hepatitis C in correctional settings.
Martin CK, Hostetter JE, Hagan JJ.
 Am J Public Health. 2010 Jan;100(1):13-7.
 Abstract

Utility of biochemical models predictive of liver fibrosis grade in inmates with hepatitis C.
Portilla J, López-Burgos A, Saiz-De-La-Hoya-Zamácola P, et al
Gastroenterol Hepatol. 2009 May 26
 Abstract

Access to Treatment of Hepatitis C in Prison Inmates.
Strock P, Mossong J, Hawotte K, Arendt V. 
Dig Dis Sci. 2008 Aug 29.
 Abstract
 
Clinical Outcomes of Hepatitis C Treatment in a Prison Setting: Feasibility and
Effectiveness for Challenging Treatment Populations.
Maru DS, Bruce RD, Basu S, Altice FL, et al 
Clin Infect Dis. 2008 Aug 20.
Abstract
 
A golden opportunity: the treatment of hepatitis C in HIV-infected inmates.
McGovern B .
J Addict Dis. 2008;27(2):69-73.
 Abstract

Expert recommendations for the diagnosis and treatment of chronic hepatitis C infection
in the prison setting.
Saiz de la Hoya-Zamacola P, Marco-Mourino A, et al
Enferm Infecc Microbiol Clin. 2006 Nov;24(9):568-75.
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
A framework for management of hepatitis C in prisons.
Spaulding AC, Weinbaum CM, Lau DT, et al
Ann Intern Med. 2006 May 16;144(10):762-9
 Abstract
 
Treatment of chronic Hepatitis C in Canadian prison inmates.
Farley JD, Wong VK, Chung HV, et al  
Can J Gastroenterol. 2005 Mar;19(3):153-6.
 Abstract
 
Treatment of chronic hepatitis C virus in the virginia department of corrections: can
compliance overcome racial differences to response?
Sterling RK, Hofmann CM, Luketic VA
Am J Gastroenterol. 2004 May;99(5):866-72
 Abstract
 
Treatment of chronic hepatitis C virus in the virginia department of corrections: can
compliance overcome racial differences to response?
Sterling RK, Hofmann CM, Luketic VA, et al 
Am J Gastroenterol. 2004 May;99(5):866-72.
Abstract

Treatment of chronic hepatitis C in a state correctional facility.
Allen SA, Spaulding AC, Osei AM
Ann Intern Med 2003 Feb 4;138(3):187-90
Abstract
Drugs
 
Peginterferon alfa-2b
 
          Journal Papers, Abstracts, and Commentaries
 
  Treatment Outcomes With Pegylated Interferon and Ribavirin for Male Prisoners With Chronic
Hepatitis C.
Chew KW, Allen SA, Taylor LE, Rich JD, Feller E.
J Clin Gastroenterol. 2009 Mar 17.
 Abstract
 
Interferon alfa-2b

          Journal Papers, Abstracts, and Commentaries
 
  Interferon alfa-2b and ribavirin: new indication. In children: more risks than in adults.
 [No authors listed 
Prescrire Int. 2007 Apr;16(88):63-5.
 Abstract

Prison Health Disease Index Main New and Noteworthy Home Page

Prisoner Health - Hepatitis C